Lung Cancer
Conference Coverage
Nasal swab test helps identify malignant lung nodules
The test is based on “field of injury” technology, which examines genomic changes in the lining of the respiratory tract for evidence of cancer...
Latest News
Urine metabolites could predict end of life in lung cancer
Conference Coverage
KRAS inhibitor improved survival in phase 2 lung cancer trial
Conference Coverage
Community practice lung cancer patients insufficiently tested for treatment-related biomarkers
Conference Coverage
NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomes
From the Journals
Drug combo disappoints as second-line therapy for advanced NSCLC with EGFR and T790M mutations
News from the FDA/CDC
First drug for lung cancer with KRAS mutation gains FDA approval
From the Journals
NSCLC survival on immunotherapy much lower in ‘real world’
Conference Coverage
Immunotherapy takes first major step into earlier NSCLC
Conference Coverage
Checkpoint inhibitors earn spot in new ESMO SCLC guidelines